These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12825833)

  • 21. A hydrosoluble triphenylene that preferentially binds acetylcholine, epibatidine, and nicotine.
    Givelet C; Buffeteau T; Arnaud-Neu F; Hubscher-Bruder V; Bibal B
    J Org Chem; 2009 Jul; 74(14):5059-62. PubMed ID: 19459648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.
    Nguyen HN; Rasmussen BA; Perry DC
    J Neurochem; 2004 Jul; 90(1):40-9. PubMed ID: 15198665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
    Kanne DB; Tomizawa M; Durkin KA; Casida JE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):877-81. PubMed ID: 15686879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volatile anesthetics reduce agonist affinity at nicotinic acetylcholine receptors in the brain.
    Rada EM; Tharakan EC; Flood P
    Anesth Analg; 2003 Jan; 96(1):108-11, table of contents. PubMed ID: 12505934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competition, Selectivity and Efficacy of Analogs of A-84543 for Nicotinic Acetylcholine Receptors with Repositioning of Pyridine Nitrogen.
    Ogunjirin AE; Fortunak JM; Brown LL; Xiao Y; Dávila-García MI
    Neurochem Res; 2015 Oct; 40(10):2131-42. PubMed ID: 26508288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
    Vainio PJ; Tuominen RK
    Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analogues.
    Carroll FI; Brieaddy LE; Navarro HA; Damaj MI; Martin BR
    J Med Chem; 2005 Nov; 48(23):7491-5. PubMed ID: 16279810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescent epibatidine agonists for neuronal and muscle-type nicotinic acetylcholine receptors.
    Grandl J; Sakr E; Kotzyba-Hibert F; Krieger F; Bertrand S; Bertrand D; Vogel H; Goeldner M; Hovius R
    Angew Chem Int Ed Engl; 2007; 46(19):3505-8. PubMed ID: 17385777
    [No Abstract]   [Full Text] [Related]  

  • 31. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S; Ahtee L; Tuominen RK
    Eur J Pharmacol; 2005 May; 515(1-3):83-9. PubMed ID: 15894304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
    Gentry CL; Wilkins LH; Lukas RJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update.
    Yogeeswari P; Sriram D; Ratan Bal T; Thirumurugan R
    Nat Prod Res; 2006 May; 20(5):497-505. PubMed ID: 16644549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.
    Shafaee N; Houng M; Truong A; Viseshakul N; Figl A; Sandhu S; Forsayeth JR; Dwoskin LP; Crooks PA; Cohen BN
    Br J Pharmacol; 1999 Nov; 128(6):1291-9. PubMed ID: 10578144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
    Wei ZL; Petukhov PA; Xiao Y; Tückmantel W; George C; Kellar KJ; Kozikowski AP
    J Med Chem; 2003 Mar; 46(6):921-4. PubMed ID: 12620069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
    Xiao Y; Kellar KJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI; Musachio JL; Kellar KJ
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
    Wei ZL; Xiao Y; Yuan H; Baydyuk M; Petukhov PA; Musachio JL; Kellar KJ; Kozikowski AP
    J Med Chem; 2005 Mar; 48(6):1721-4. PubMed ID: 15771418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.